nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Drug hypersensitivity—Varenicline—nicotine dependence	0.0194	0.0757	CcSEcCtD
Bosutinib—Rash generalised—Varenicline—nicotine dependence	0.0184	0.0717	CcSEcCtD
Bosutinib—Pancreatitis acute—Varenicline—nicotine dependence	0.0169	0.066	CcSEcCtD
Bosutinib—Acne—Varenicline—nicotine dependence	0.00929	0.0362	CcSEcCtD
Bosutinib—Chest discomfort—Varenicline—nicotine dependence	0.00883	0.0345	CcSEcCtD
Bosutinib—Hyperkalaemia—Varenicline—nicotine dependence	0.00768	0.0299	CcSEcCtD
Bosutinib—BMX—cardiovascular system—nicotine dependence	0.00621	0.0136	CbGeAlD
Bosutinib—Renal failure acute—Varenicline—nicotine dependence	0.00614	0.024	CcSEcCtD
Bosutinib—PHKG1—cardiovascular system—nicotine dependence	0.00607	0.0133	CbGeAlD
Bosutinib—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00567	0.0221	CcSEcCtD
Bosutinib—CDK2—cardiovascular system—nicotine dependence	0.00565	0.0124	CbGeAlD
Bosutinib—WEE1—cardiovascular system—nicotine dependence	0.00536	0.0117	CbGeAlD
Bosutinib—DMPK—cardiovascular system—nicotine dependence	0.00536	0.0117	CbGeAlD
Bosutinib—Abdominal pain upper—Varenicline—nicotine dependence	0.00518	0.0202	CcSEcCtD
Bosutinib—PRKCQ—midbrain—nicotine dependence	0.00517	0.0113	CbGeAlD
Bosutinib—Nasopharyngitis—Varenicline—nicotine dependence	0.00507	0.0198	CcSEcCtD
Bosutinib—Gastritis—Varenicline—nicotine dependence	0.00502	0.0196	CcSEcCtD
Bosutinib—PLK2—cardiovascular system—nicotine dependence	0.00498	0.0109	CbGeAlD
Bosutinib—DSTYK—midbrain—nicotine dependence	0.00485	0.0106	CbGeAlD
Bosutinib—Bronchitis—Varenicline—nicotine dependence	0.00471	0.0184	CcSEcCtD
Bosutinib—Abdominal discomfort—Varenicline—nicotine dependence	0.0047	0.0183	CcSEcCtD
Bosutinib—EIF2AK1—midbrain—nicotine dependence	0.00469	0.0103	CbGeAlD
Bosutinib—VRK2—midbrain—nicotine dependence	0.00454	0.00995	CbGeAlD
Bosutinib—TNIK—midbrain—nicotine dependence	0.00446	0.00975	CbGeAlD
Bosutinib—SYK—midbrain—nicotine dependence	0.00446	0.00975	CbGeAlD
Bosutinib—Infestation NOS—Varenicline—nicotine dependence	0.00437	0.0171	CcSEcCtD
Bosutinib—Infestation—Varenicline—nicotine dependence	0.00437	0.0171	CcSEcCtD
Bosutinib—ERBB4—cardiovascular system—nicotine dependence	0.00421	0.00921	CbGeAlD
Bosutinib—DMPK—midbrain—nicotine dependence	0.00419	0.00917	CbGeAlD
Bosutinib—ROCK1—cardiovascular system—nicotine dependence	0.00415	0.00909	CbGeAlD
Bosutinib—Hepatobiliary disease—Varenicline—nicotine dependence	0.00413	0.0161	CcSEcCtD
Bosutinib—BMPR2—cardiovascular system—nicotine dependence	0.00403	0.00883	CbGeAlD
Bosutinib—STK25—midbrain—nicotine dependence	0.004	0.00876	CbGeAlD
Bosutinib—PLK2—midbrain—nicotine dependence	0.00389	0.00851	CbGeAlD
Bosutinib—MAP4K4—cardiovascular system—nicotine dependence	0.00388	0.0085	CbGeAlD
Bosutinib—Urinary tract disorder—Varenicline—nicotine dependence	0.00388	0.0151	CcSEcCtD
Bosutinib—Oedema peripheral—Varenicline—nicotine dependence	0.00387	0.0151	CcSEcCtD
Bosutinib—SIK3—midbrain—nicotine dependence	0.00386	0.00846	CbGeAlD
Bosutinib—Connective tissue disorder—Varenicline—nicotine dependence	0.00386	0.015	CcSEcCtD
Bosutinib—Urethral disorder—Varenicline—nicotine dependence	0.00385	0.015	CcSEcCtD
Bosutinib—MAP2K1—cardiovascular system—nicotine dependence	0.00375	0.00821	CbGeAlD
Bosutinib—CSK—cardiovascular system—nicotine dependence	0.00372	0.00815	CbGeAlD
Bosutinib—Erythema multiforme—Varenicline—nicotine dependence	0.00371	0.0145	CcSEcCtD
Bosutinib—CSNK1A1—cardiovascular system—nicotine dependence	0.0037	0.0081	CbGeAlD
Bosutinib—MAST1—brain—nicotine dependence	0.00369	0.00809	CbGeAlD
Bosutinib—CLK1—cardiovascular system—nicotine dependence	0.00368	0.00805	CbGeAlD
Bosutinib—Tinnitus—Varenicline—nicotine dependence	0.00366	0.0143	CcSEcCtD
Bosutinib—Cardiac disorder—Varenicline—nicotine dependence	0.00364	0.0142	CcSEcCtD
Bosutinib—CAMK2G—cardiovascular system—nicotine dependence	0.00361	0.0079	CbGeAlD
Bosutinib—Immune system disorder—Varenicline—nicotine dependence	0.00354	0.0138	CcSEcCtD
Bosutinib—Mediastinal disorder—Varenicline—nicotine dependence	0.00354	0.0138	CcSEcCtD
Bosutinib—EPHA5—midbrain—nicotine dependence	0.00351	0.00769	CbGeAlD
Bosutinib—ALK—midbrain—nicotine dependence	0.00351	0.00769	CbGeAlD
Bosutinib—FER—midbrain—nicotine dependence	0.00351	0.00769	CbGeAlD
Bosutinib—PTK2B—cardiovascular system—nicotine dependence	0.00349	0.00763	CbGeAlD
Bosutinib—Malnutrition—Varenicline—nicotine dependence	0.00342	0.0133	CcSEcCtD
Bosutinib—Dysgeusia—Varenicline—nicotine dependence	0.00334	0.013	CcSEcCtD
Bosutinib—MAP4K2—midbrain—nicotine dependence	0.00333	0.00729	CbGeAlD
Bosutinib—Back pain—Varenicline—nicotine dependence	0.0033	0.0129	CcSEcCtD
Bosutinib—MAP2K2—cardiovascular system—nicotine dependence	0.0033	0.00723	CbGeAlD
Bosutinib—TLK1—brain—nicotine dependence	0.00329	0.00721	CbGeAlD
Bosutinib—ERBB4—midbrain—nicotine dependence	0.00328	0.00719	CbGeAlD
Bosutinib—PRKCQ—brain—nicotine dependence	0.00325	0.00711	CbGeAlD
Bosutinib—TBK1—cardiovascular system—nicotine dependence	0.00321	0.00703	CbGeAlD
Bosutinib—PTK2—cardiovascular system—nicotine dependence	0.00321	0.00703	CbGeAlD
Bosutinib—SIK2—brain—nicotine dependence	0.0032	0.00701	CbGeAlD
Bosutinib—STK33—brain—nicotine dependence	0.0032	0.00701	CbGeAlD
Bosutinib—Ill-defined disorder—Varenicline—nicotine dependence	0.00317	0.0124	CcSEcCtD
Bosutinib—Anaemia—Varenicline—nicotine dependence	0.00316	0.0123	CcSEcCtD
Bosutinib—BMPR2—midbrain—nicotine dependence	0.00315	0.00689	CbGeAlD
Bosutinib—PKMYT1—brain—nicotine dependence	0.00312	0.00683	CbGeAlD
Bosutinib—RPS6KB1—cardiovascular system—nicotine dependence	0.00309	0.00676	CbGeAlD
Bosutinib—Malaise—Varenicline—nicotine dependence	0.00308	0.012	CcSEcCtD
Bosutinib—FGR—cardiovascular system—nicotine dependence	0.00307	0.00672	CbGeAlD
Bosutinib—AXL—cardiovascular system—nicotine dependence	0.00306	0.00669	CbGeAlD
Bosutinib—CLK3—brain—nicotine dependence	0.00305	0.00667	CbGeAlD
Bosutinib—DSTYK—brain—nicotine dependence	0.00305	0.00667	CbGeAlD
Bosutinib—MAP4K4—midbrain—nicotine dependence	0.00303	0.00664	CbGeAlD
Bosutinib—HIPK4—brain—nicotine dependence	0.00301	0.00659	CbGeAlD
Bosutinib—BCR—midbrain—nicotine dependence	0.00301	0.00659	CbGeAlD
Bosutinib—MAP3K12—midbrain—nicotine dependence	0.00299	0.00654	CbGeAlD
Bosutinib—Cough—Varenicline—nicotine dependence	0.00298	0.0116	CcSEcCtD
Bosutinib—PHKG1—brain—nicotine dependence	0.00298	0.00652	CbGeAlD
Bosutinib—CASK—brain—nicotine dependence	0.00298	0.00652	CbGeAlD
Bosutinib—EPHB2—brain—nicotine dependence	0.00298	0.00652	CbGeAlD
Bosutinib—EIF2AK1—brain—nicotine dependence	0.00295	0.00645	CbGeAlD
Bosutinib—STK35—midbrain—nicotine dependence	0.00293	0.00641	CbGeAlD
Bosutinib—EPHB4—cardiovascular system—nicotine dependence	0.00292	0.00639	CbGeAlD
Bosutinib—SRMS—brain—nicotine dependence	0.00291	0.00638	CbGeAlD
Bosutinib—CSK—midbrain—nicotine dependence	0.00291	0.00637	CbGeAlD
Bosutinib—Chest pain—Varenicline—nicotine dependence	0.00291	0.0113	CcSEcCtD
Bosutinib—Arthralgia—Varenicline—nicotine dependence	0.00291	0.0113	CcSEcCtD
Bosutinib—Myalgia—Varenicline—nicotine dependence	0.00291	0.0113	CcSEcCtD
Bosutinib—CSNK1A1—midbrain—nicotine dependence	0.00289	0.00633	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00289	0.0113	CcSEcCtD
Bosutinib—Discomfort—Varenicline—nicotine dependence	0.00287	0.0112	CcSEcCtD
Bosutinib—HCK—midbrain—nicotine dependence	0.00287	0.00629	CbGeAlD
Bosutinib—CLK1—midbrain—nicotine dependence	0.00287	0.00629	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—nicotine dependence	0.00287	0.00627	CbGeAlD
Bosutinib—FYN—cardiovascular system—nicotine dependence	0.00286	0.00626	CbGeAlD
Bosutinib—VRK2—brain—nicotine dependence	0.00285	0.00625	CbGeAlD
Bosutinib—EPHA8—brain—nicotine dependence	0.00285	0.00625	CbGeAlD
Bosutinib—FES—brain—nicotine dependence	0.00285	0.00625	CbGeAlD
Bosutinib—CAMK2G—midbrain—nicotine dependence	0.00282	0.00617	CbGeAlD
Bosutinib—BMP2K—midbrain—nicotine dependence	0.00282	0.00617	CbGeAlD
Bosutinib—TNIK—brain—nicotine dependence	0.0028	0.00613	CbGeAlD
Bosutinib—SYK—brain—nicotine dependence	0.0028	0.00613	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—nicotine dependence	0.0028	0.00612	CbGeAlD
Bosutinib—LRRK2—midbrain—nicotine dependence	0.00279	0.00611	CbGeAlD
Bosutinib—Oedema—Varenicline—nicotine dependence	0.00279	0.0109	CcSEcCtD
Bosutinib—CDK2—brain—nicotine dependence	0.00277	0.00607	CbGeAlD
Bosutinib—Infection—Varenicline—nicotine dependence	0.00277	0.0108	CcSEcCtD
Bosutinib—STK26—brain—nicotine dependence	0.00275	0.00602	CbGeAlD
Bosutinib—Nervous system disorder—Varenicline—nicotine dependence	0.00273	0.0107	CcSEcCtD
Bosutinib—Thrombocytopenia—Varenicline—nicotine dependence	0.00273	0.0106	CcSEcCtD
Bosutinib—Skin disorder—Varenicline—nicotine dependence	0.00271	0.0106	CcSEcCtD
Bosutinib—CSNK1E—midbrain—nicotine dependence	0.00268	0.00586	CbGeAlD
Bosutinib—CHEK2—brain—nicotine dependence	0.00265	0.00581	CbGeAlD
Bosutinib—WEE1—brain—nicotine dependence	0.00263	0.00576	CbGeAlD
Bosutinib—DMPK—brain—nicotine dependence	0.00263	0.00576	CbGeAlD
Bosutinib—ERBB3—midbrain—nicotine dependence	0.00258	0.00566	CbGeAlD
Bosutinib—MAP2K2—midbrain—nicotine dependence	0.00258	0.00564	CbGeAlD
Bosutinib—ULK3—midbrain—nicotine dependence	0.00258	0.00564	CbGeAlD
Bosutinib—STK10—cardiovascular system—nicotine dependence	0.00256	0.0056	CbGeAlD
Bosutinib—TAOK3—cardiovascular system—nicotine dependence	0.00255	0.00558	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00254	0.00991	CcSEcCtD
Bosutinib—MAP3K7—midbrain—nicotine dependence	0.00254	0.00555	CbGeAlD
Bosutinib—STK25—brain—nicotine dependence	0.00251	0.0055	CbGeAlD
Bosutinib—PTK2—midbrain—nicotine dependence	0.00251	0.00549	CbGeAlD
Bosutinib—TBK1—midbrain—nicotine dependence	0.00251	0.00549	CbGeAlD
Bosutinib—EPHA3—brain—nicotine dependence	0.0025	0.00546	CbGeAlD
Bosutinib—Dyspnoea—Varenicline—nicotine dependence	0.00249	0.0097	CcSEcCtD
Bosutinib—SRC—cardiovascular system—nicotine dependence	0.00248	0.00544	CbGeAlD
Bosutinib—IRAK1—midbrain—nicotine dependence	0.00246	0.00538	CbGeAlD
Bosutinib—PLK2—brain—nicotine dependence	0.00244	0.00535	CbGeAlD
Bosutinib—SIK3—brain—nicotine dependence	0.00243	0.00531	CbGeAlD
Bosutinib—Decreased appetite—Varenicline—nicotine dependence	0.00242	0.00945	CcSEcCtD
Bosutinib—RPS6KB1—midbrain—nicotine dependence	0.00241	0.00528	CbGeAlD
Bosutinib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00241	0.00939	CcSEcCtD
Bosutinib—Fatigue—Varenicline—nicotine dependence	0.0024	0.00938	CcSEcCtD
Bosutinib—AXL—midbrain—nicotine dependence	0.00239	0.00522	CbGeAlD
Bosutinib—Pain—Varenicline—nicotine dependence	0.00238	0.0093	CcSEcCtD
Bosutinib—STK4—brain—nicotine dependence	0.00234	0.00512	CbGeAlD
Bosutinib—CAMK1D—brain—nicotine dependence	0.00231	0.00505	CbGeAlD
Bosutinib—SLK—midbrain—nicotine dependence	0.0023	0.00503	CbGeAlD
Bosutinib—Feeling abnormal—Varenicline—nicotine dependence	0.0023	0.00896	CcSEcCtD
Bosutinib—MAP2K5—cardiovascular system—nicotine dependence	0.00228	0.005	CbGeAlD
Bosutinib—STK24—brain—nicotine dependence	0.00228	0.005	CbGeAlD
Bosutinib—EPHB4—midbrain—nicotine dependence	0.00228	0.00499	CbGeAlD
Bosutinib—Gastrointestinal pain—Varenicline—nicotine dependence	0.00228	0.00889	CcSEcCtD
Bosutinib—FYN—midbrain—nicotine dependence	0.00223	0.00489	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—nicotine dependence	0.00223	0.00488	CbGeAlD
Bosutinib—Urticaria—Varenicline—nicotine dependence	0.00221	0.00864	CcSEcCtD
Bosutinib—FER—brain—nicotine dependence	0.00221	0.00483	CbGeAlD
Bosutinib—ALK—brain—nicotine dependence	0.00221	0.00483	CbGeAlD
Bosutinib—EPHA5—brain—nicotine dependence	0.00221	0.00483	CbGeAlD
Bosutinib—TYRO3—brain—nicotine dependence	0.00221	0.00483	CbGeAlD
Bosutinib—Body temperature increased—Varenicline—nicotine dependence	0.0022	0.0086	CcSEcCtD
Bosutinib—Abdominal pain—Varenicline—nicotine dependence	0.0022	0.0086	CcSEcCtD
Bosutinib—LYN—brain—nicotine dependence	0.0022	0.00481	CbGeAlD
Bosutinib—MAP4K5—midbrain—nicotine dependence	0.00218	0.00478	CbGeAlD
Bosutinib—MAP3K3—midbrain—nicotine dependence	0.00218	0.00478	CbGeAlD
Bosutinib—MAP3K19—brain—nicotine dependence	0.00216	0.00474	CbGeAlD
Bosutinib—MAP4K1—brain—nicotine dependence	0.00216	0.00474	CbGeAlD
Bosutinib—BTK—brain—nicotine dependence	0.00215	0.00471	CbGeAlD
Bosutinib—TNK2—brain—nicotine dependence	0.00212	0.00465	CbGeAlD
Bosutinib—MAP4K2—brain—nicotine dependence	0.00209	0.00458	CbGeAlD
Bosutinib—STK3—brain—nicotine dependence	0.00206	0.00452	CbGeAlD
Bosutinib—ERBB4—brain—nicotine dependence	0.00206	0.00452	CbGeAlD
Bosutinib—ROCK1—brain—nicotine dependence	0.00204	0.00446	CbGeAlD
Bosutinib—YES1—midbrain—nicotine dependence	0.00202	0.00441	CbGeAlD
Bosutinib—Asthenia—Varenicline—nicotine dependence	0.002	0.0078	CcSEcCtD
Bosutinib—TAOK3—midbrain—nicotine dependence	0.00199	0.00436	CbGeAlD
Bosutinib—BMPR2—brain—nicotine dependence	0.00198	0.00433	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—nicotine dependence	0.00198	0.00433	CbGeAlD
Bosutinib—Pruritus—Varenicline—nicotine dependence	0.00197	0.00769	CcSEcCtD
Bosutinib—EPHB3—brain—nicotine dependence	0.00196	0.0043	CbGeAlD
Bosutinib—STK36—brain—nicotine dependence	0.00196	0.0043	CbGeAlD
Bosutinib—MERTK—brain—nicotine dependence	0.00194	0.00425	CbGeAlD
Bosutinib—Diarrhoea—Varenicline—nicotine dependence	0.00191	0.00744	CcSEcCtD
Bosutinib—MAP4K4—brain—nicotine dependence	0.0019	0.00417	CbGeAlD
Bosutinib—NUAK2—brain—nicotine dependence	0.00189	0.00414	CbGeAlD
Bosutinib—BCR—brain—nicotine dependence	0.00189	0.00414	CbGeAlD
Bosutinib—MAP3K12—brain—nicotine dependence	0.00188	0.00411	CbGeAlD
Bosutinib—Dizziness—Varenicline—nicotine dependence	0.00184	0.00719	CcSEcCtD
Bosutinib—MAP2K1—brain—nicotine dependence	0.00184	0.00403	CbGeAlD
Bosutinib—STK35—brain—nicotine dependence	0.00184	0.00403	CbGeAlD
Bosutinib—CSK—brain—nicotine dependence	0.00183	0.004	CbGeAlD
Bosutinib—CSNK1A1—brain—nicotine dependence	0.00182	0.00397	CbGeAlD
Bosutinib—CLK1—brain—nicotine dependence	0.0018	0.00395	CbGeAlD
Bosutinib—HCK—brain—nicotine dependence	0.0018	0.00395	CbGeAlD
Bosutinib—ABL2—brain—nicotine dependence	0.00179	0.00392	CbGeAlD
Bosutinib—MAP2K5—midbrain—nicotine dependence	0.00178	0.00391	CbGeAlD
Bosutinib—Vomiting—Varenicline—nicotine dependence	0.00177	0.00691	CcSEcCtD
Bosutinib—CAMK2G—brain—nicotine dependence	0.00177	0.00388	CbGeAlD
Bosutinib—BMP2K—brain—nicotine dependence	0.00177	0.00388	CbGeAlD
Bosutinib—ABL1—cardiovascular system—nicotine dependence	0.00176	0.00386	CbGeAlD
Bosutinib—Rash—Varenicline—nicotine dependence	0.00176	0.00686	CcSEcCtD
Bosutinib—Dermatitis—Varenicline—nicotine dependence	0.00176	0.00685	CcSEcCtD
Bosutinib—LRRK2—brain—nicotine dependence	0.00175	0.00384	CbGeAlD
Bosutinib—EGFR—brain—nicotine dependence	0.00175	0.00383	CbGeAlD
Bosutinib—Headache—Varenicline—nicotine dependence	0.00175	0.00681	CcSEcCtD
Bosutinib—CSF1R—midbrain—nicotine dependence	0.00174	0.00381	CbGeAlD
Bosutinib—PTK2B—brain—nicotine dependence	0.00171	0.00374	CbGeAlD
Bosutinib—CSNK1E—brain—nicotine dependence	0.00168	0.00368	CbGeAlD
Bosutinib—SIK1—brain—nicotine dependence	0.00166	0.00363	CbGeAlD
Bosutinib—IRAK4—brain—nicotine dependence	0.00166	0.00363	CbGeAlD
Bosutinib—Nausea—Varenicline—nicotine dependence	0.00166	0.00646	CcSEcCtD
Bosutinib—EPHA4—brain—nicotine dependence	0.00164	0.00359	CbGeAlD
Bosutinib—ERBB3—brain—nicotine dependence	0.00162	0.00355	CbGeAlD
Bosutinib—ULK3—brain—nicotine dependence	0.00162	0.00355	CbGeAlD
Bosutinib—MAP2K2—brain—nicotine dependence	0.00162	0.00355	CbGeAlD
Bosutinib—MAP3K2—brain—nicotine dependence	0.00161	0.00352	CbGeAlD
Bosutinib—MAP3K7—brain—nicotine dependence	0.00159	0.00349	CbGeAlD
Bosutinib—TBK1—brain—nicotine dependence	0.00157	0.00345	CbGeAlD
Bosutinib—PTK2—brain—nicotine dependence	0.00157	0.00345	CbGeAlD
Bosutinib—PDGFRB—midbrain—nicotine dependence	0.00154	0.00338	CbGeAlD
Bosutinib—IRAK1—brain—nicotine dependence	0.00154	0.00338	CbGeAlD
Bosutinib—RPS6KB1—brain—nicotine dependence	0.00151	0.00332	CbGeAlD
Bosutinib—FGR—brain—nicotine dependence	0.00151	0.0033	CbGeAlD
Bosutinib—AXL—brain—nicotine dependence	0.0015	0.00328	CbGeAlD
Bosutinib—SLK—brain—nicotine dependence	0.00144	0.00316	CbGeAlD
Bosutinib—EPHB4—brain—nicotine dependence	0.00143	0.00314	CbGeAlD
Bosutinib—EPHA2—brain—nicotine dependence	0.00141	0.00308	CbGeAlD
Bosutinib—FYN—brain—nicotine dependence	0.0014	0.00307	CbGeAlD
Bosutinib—ABL1—midbrain—nicotine dependence	0.00138	0.00301	CbGeAlD
Bosutinib—MAP4K5—brain—nicotine dependence	0.00137	0.003	CbGeAlD
Bosutinib—MAP3K3—brain—nicotine dependence	0.00137	0.003	CbGeAlD
Bosutinib—YES1—brain—nicotine dependence	0.00127	0.00277	CbGeAlD
Bosutinib—STK10—brain—nicotine dependence	0.00126	0.00275	CbGeAlD
Bosutinib—TAOK3—brain—nicotine dependence	0.00125	0.00274	CbGeAlD
Bosutinib—SRC—brain—nicotine dependence	0.00122	0.00267	CbGeAlD
Bosutinib—MAP2K5—brain—nicotine dependence	0.00112	0.00245	CbGeAlD
Bosutinib—CSF1R—brain—nicotine dependence	0.00109	0.0024	CbGeAlD
Bosutinib—PDGFRB—brain—nicotine dependence	0.00097	0.00212	CbGeAlD
Bosutinib—ABL1—brain—nicotine dependence	0.000865	0.00189	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—nicotine dependence	0.000548	0.0012	CbGeAlD
Bosutinib—ABCB1—midbrain—nicotine dependence	0.000428	0.000937	CbGeAlD
Bosutinib—ABCB1—brain—nicotine dependence	0.000269	0.000589	CbGeAlD
Bosutinib—AXL—Signaling Pathways—OPRM1—nicotine dependence	0.000253	0.000881	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—WASF2—nicotine dependence	0.000251	0.000875	CbGpPWpGaD
Bosutinib—TBK1—Immune System—WASF1—nicotine dependence	0.000251	0.000875	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—WASF2—nicotine dependence	0.00025	0.000873	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—WASF1—nicotine dependence	0.000246	0.000859	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TAS2R16—nicotine dependence	0.000246	0.000859	CbGpPWpGaD
Bosutinib—BTK—Immune System—WASF2—nicotine dependence	0.000244	0.000851	CbGpPWpGaD
Bosutinib—ERBB3—Disease—AKR1B10—nicotine dependence	0.000244	0.00085	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—OPRM1—nicotine dependence	0.000241	0.000841	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—WASF1—nicotine dependence	0.000241	0.000839	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—WASF1—nicotine dependence	0.00024	0.000837	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—WASF2—nicotine dependence	0.000234	0.000816	CbGpPWpGaD
Bosutinib—BTK—Immune System—WASF1—nicotine dependence	0.000234	0.000816	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—WASF2—nicotine dependence	0.000233	0.000813	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—TAS2R16—nicotine dependence	0.000232	0.000809	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—OPRM1—nicotine dependence	0.000231	0.000806	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—DRD2—nicotine dependence	0.00023	0.000802	CbGpPWpGaD
Bosutinib—PRKCQ—GPCR downstream signaling—DRD2—nicotine dependence	0.000227	0.000793	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—WASF1—nicotine dependence	0.000224	0.000783	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—FGD1—nicotine dependence	0.000224	0.000781	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—AKR1B10—nicotine dependence	0.000224	0.000781	CbGpPWpGaD
Bosutinib—HCK—Immune System—WASF2—nicotine dependence	0.000224	0.000781	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—WASF1—nicotine dependence	0.000224	0.00078	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—FGD1—nicotine dependence	0.000219	0.000764	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TAS2R16—nicotine dependence	0.000219	0.000764	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—WASF2—nicotine dependence	0.000219	0.000763	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TAS2R16—nicotine dependence	0.000216	0.000754	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—FGD1—nicotine dependence	0.000216	0.000753	CbGpPWpGaD
Bosutinib—HCK—Immune System—WASF1—nicotine dependence	0.000215	0.000749	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—WASF2—nicotine dependence	0.000214	0.000744	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—WASF2—nicotine dependence	0.000211	0.000736	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—WASF1—nicotine dependence	0.00021	0.000731	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—FGD1—nicotine dependence	0.00021	0.000731	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—WASF2—nicotine dependence	0.000209	0.000729	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000208	0.000727	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—FGD1—nicotine dependence	0.000208	0.000726	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—WASF2—nicotine dependence	0.000208	0.000725	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—WASF2—nicotine dependence	0.000208	0.000725	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—DRD2—nicotine dependence	0.000206	0.00072	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—WASF2—nicotine dependence	0.000206	0.000718	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000205	0.000715	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—WASF2—nicotine dependence	0.000205	0.000714	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—WASF1—nicotine dependence	0.000205	0.000714	CbGpPWpGaD
Bosutinib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000204	0.000711	CbGpPWpGaD
Bosutinib—BLK—Immune System—WASF2—nicotine dependence	0.000203	0.000708	CbGpPWpGaD
Bosutinib—FGR—Immune System—WASF2—nicotine dependence	0.000202	0.000705	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—WASF1—nicotine dependence	0.000202	0.000705	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—OPRM1—nicotine dependence	0.000202	0.000705	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—FGD1—nicotine dependence	0.000201	0.000699	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—FGD1—nicotine dependence	0.000201	0.000699	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—WASF1—nicotine dependence	0.0002	0.000699	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—WASF1—nicotine dependence	0.0002	0.000696	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—WASF1—nicotine dependence	0.000199	0.000695	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—WASF2—nicotine dependence	0.000199	0.000694	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—WASF1—nicotine dependence	0.000197	0.000688	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—WASF1—nicotine dependence	0.000196	0.000684	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.000681	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.000681	CbGpPWpGaD
Bosutinib—BLK—Immune System—WASF1—nicotine dependence	0.000195	0.000678	CbGpPWpGaD
Bosutinib—FGR—Immune System—WASF1—nicotine dependence	0.000194	0.000676	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKR1B10—nicotine dependence	0.000194	0.000675	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—FGD1—nicotine dependence	0.000193	0.000674	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TAS2R16—nicotine dependence	0.000193	0.000673	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—DRD2—nicotine dependence	0.000193	0.000672	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000192	0.00067	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—WASF1—nicotine dependence	0.000191	0.000665	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000191	0.000665	CbGpPWpGaD
Bosutinib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00019	0.000661	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—OPRM1—nicotine dependence	0.000189	0.00066	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—WASF2—nicotine dependence	0.000189	0.000658	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.000653	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.000653	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—WASF2—nicotine dependence	0.000186	0.000649	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000184	0.000641	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—DRD2—nicotine dependence	0.000183	0.000637	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—FGD1—nicotine dependence	0.000182	0.000635	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—WASF1—nicotine dependence	0.000181	0.000631	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—WASF1—nicotine dependence	0.000178	0.000622	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—WASF2—nicotine dependence	0.000178	0.00062	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000177	0.000617	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKR1B10—nicotine dependence	0.000177	0.000617	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—DRD2—nicotine dependence	0.000174	0.000608	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—FGD1—nicotine dependence	0.000172	0.0006	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—OPRM1—nicotine dependence	0.000172	0.000599	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—WASF2—nicotine dependence	0.000171	0.000597	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKR1B10—nicotine dependence	0.000171	0.000595	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—WASF1—nicotine dependence	0.000171	0.000594	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—FGD1—nicotine dependence	0.00017	0.000591	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TAS2R16—nicotine dependence	0.000169	0.000588	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—OPRM1—nicotine dependence	0.000169	0.000588	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—OPRM1—nicotine dependence	0.000169	0.000588	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—DRD2—nicotine dependence	0.000167	0.000583	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKR1B10—nicotine dependence	0.000167	0.000582	CbGpPWpGaD
Bosutinib—PTK2—Immune System—WASF2—nicotine dependence	0.000166	0.000577	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TAS2R16—nicotine dependence	0.000165	0.000574	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—WASF1—nicotine dependence	0.000164	0.000573	CbGpPWpGaD
Bosutinib—YES1—Immune System—WASF2—nicotine dependence	0.000163	0.000569	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKR1B10—nicotine dependence	0.000163	0.000568	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—OPRM1—nicotine dependence	0.000163	0.000568	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000161	0.000562	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—FGD1—nicotine dependence	0.000161	0.000561	CbGpPWpGaD
Bosutinib—PTK2—Immune System—WASF1—nicotine dependence	0.000159	0.000553	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TAS2R16—nicotine dependence	0.000159	0.000553	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TAS2R16—nicotine dependence	0.000158	0.00055	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—WASF2—nicotine dependence	0.000158	0.00055	CbGpPWpGaD
Bosutinib—FYN—Disease—AKR1B10—nicotine dependence	0.000157	0.000548	CbGpPWpGaD
Bosutinib—YES1—Immune System—WASF1—nicotine dependence	0.000157	0.000546	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKR1B10—nicotine dependence	0.000156	0.000545	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—WASF2—nicotine dependence	0.000155	0.00054	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKR1B10—nicotine dependence	0.000152	0.00053	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—WASF2—nicotine dependence	0.000152	0.000529	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—FGD1—nicotine dependence	0.000152	0.000528	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—WASF1—nicotine dependence	0.000151	0.000528	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—DRD2—nicotine dependence	0.000151	0.000525	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKR1B10—nicotine dependence	0.00015	0.000522	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—WASF1—nicotine dependence	0.000149	0.000518	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—DRD2—nicotine dependence	0.000146	0.000509	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—WASF2—nicotine dependence	0.000146	0.000508	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—WASF1—nicotine dependence	0.000145	0.000507	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000142	0.000496	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—WASF1—nicotine dependence	0.00014	0.000487	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TAS2R16—nicotine dependence	0.000137	0.000478	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—DRD2—nicotine dependence	0.000137	0.000477	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—WASF2—nicotine dependence	0.000136	0.000476	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—OPRM1—nicotine dependence	0.000136	0.000475	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKR1B10—nicotine dependence	0.000136	0.000473	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—WASF2—nicotine dependence	0.000134	0.000469	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKR1B10—nicotine dependence	0.000134	0.000467	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—FGD1—nicotine dependence	0.000132	0.000462	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TAS2R16—nicotine dependence	0.000132	0.000461	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—WASF1—nicotine dependence	0.000131	0.000456	CbGpPWpGaD
Bosutinib—LCK—Disease—AKR1B10—nicotine dependence	0.000131	0.000456	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—WASF2—nicotine dependence	0.00013	0.000452	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—FGD1—nicotine dependence	0.000129	0.00045	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—WASF1—nicotine dependence	0.000129	0.000449	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—WASF2—nicotine dependence	0.000127	0.000444	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—FGD1—nicotine dependence	0.000127	0.000441	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—WASF2—nicotine dependence	0.000125	0.000435	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—WASF2—nicotine dependence	0.000125	0.000435	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—FGD1—nicotine dependence	0.000125	0.000434	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—WASF2—nicotine dependence	0.000124	0.000434	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—DRD2—nicotine dependence	0.000124	0.000433	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—WASF1—nicotine dependence	0.000124	0.000433	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—FGD1—nicotine dependence	0.000124	0.000432	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—WASF1—nicotine dependence	0.000122	0.000426	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000425	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000425	CbGpPWpGaD
Bosutinib—LYN—Immune System—WASF2—nicotine dependence	0.000122	0.000425	CbGpPWpGaD
Bosutinib—ABL1—Immune System—WASF2—nicotine dependence	0.000121	0.000423	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—OPRM1—nicotine dependence	0.00012	0.00042	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—WASF2—nicotine dependence	0.00012	0.000419	CbGpPWpGaD
Bosutinib—FYN—Immune System—WASF2—nicotine dependence	0.00012	0.000418	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—WASF1—nicotine dependence	0.00012	0.000417	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—WASF1—nicotine dependence	0.00012	0.000417	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—WASF2—nicotine dependence	0.000119	0.000416	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—WASF1—nicotine dependence	0.000119	0.000416	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—OPRM1—nicotine dependence	0.000118	0.000411	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—DRD2—nicotine dependence	0.000118	0.000411	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TAS2R16—nicotine dependence	0.000117	0.000408	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKR1B10—nicotine dependence	0.000117	0.000408	CbGpPWpGaD
Bosutinib—LYN—Immune System—WASF1—nicotine dependence	0.000117	0.000407	CbGpPWpGaD
Bosutinib—ABL1—Immune System—WASF1—nicotine dependence	0.000116	0.000405	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—OPRM1—nicotine dependence	0.000116	0.000405	CbGpPWpGaD
Bosutinib—SRC—Disease—AKR1B10—nicotine dependence	0.000116	0.000404	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—WASF1—nicotine dependence	0.000115	0.000402	CbGpPWpGaD
Bosutinib—FYN—Immune System—WASF1—nicotine dependence	0.000115	0.000401	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—WASF1—nicotine dependence	0.000114	0.000399	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKR1B10—nicotine dependence	0.000114	0.000398	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000114	0.000397	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—OPRM1—nicotine dependence	0.000113	0.000393	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—OPRM1—nicotine dependence	0.000112	0.00039	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKR1B10—nicotine dependence	0.000112	0.00039	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKR1B10—nicotine dependence	0.00011	0.000384	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKR1B10—nicotine dependence	0.000109	0.000381	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—OPRM1—nicotine dependence	0.000108	0.000376	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—OPRM1—nicotine dependence	0.000108	0.000376	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGD1—nicotine dependence	0.000108	0.000375	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—WASF2—nicotine dependence	0.000107	0.000373	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—WASF2—nicotine dependence	0.000106	0.000368	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—OPRM1—nicotine dependence	0.000104	0.000362	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGD1—nicotine dependence	0.000104	0.000361	CbGpPWpGaD
Bosutinib—EGFR—Immune System—WASF2—nicotine dependence	0.000104	0.000361	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—WASF1—nicotine dependence	0.000103	0.000358	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—WASF1—nicotine dependence	0.000101	0.000353	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—WASF2—nicotine dependence	0.0001	0.000349	CbGpPWpGaD
Bosutinib—LCK—Immune System—WASF2—nicotine dependence	9.98e-05	0.000348	CbGpPWpGaD
Bosutinib—EGFR—Immune System—WASF1—nicotine dependence	9.93e-05	0.000346	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—DRD2—nicotine dependence	9.85e-05	0.000343	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—OPRM1—nicotine dependence	9.79e-05	0.000341	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—WASF1—nicotine dependence	9.6e-05	0.000335	CbGpPWpGaD
Bosutinib—LCK—Immune System—WASF1—nicotine dependence	9.57e-05	0.000334	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKR1B10—nicotine dependence	9.51e-05	0.000331	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—WASF2—nicotine dependence	9.43e-05	0.000329	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—OPRM1—nicotine dependence	9.24e-05	0.000322	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGD1—nicotine dependence	9.18e-05	0.00032	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKR1B10—nicotine dependence	9.16e-05	0.000319	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—OPRM1—nicotine dependence	9.12e-05	0.000318	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—WASF1—nicotine dependence	9.04e-05	0.000315	CbGpPWpGaD
Bosutinib—SRC—Immune System—WASF2—nicotine dependence	8.84e-05	0.000308	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—DRD2—nicotine dependence	8.71e-05	0.000303	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—OPRM1—nicotine dependence	8.65e-05	0.000301	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—DRD2—nicotine dependence	8.52e-05	0.000297	CbGpPWpGaD
Bosutinib—SRC—Immune System—WASF1—nicotine dependence	8.47e-05	0.000295	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—DRD2—nicotine dependence	8.39e-05	0.000293	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—WASF2—nicotine dependence	8.24e-05	0.000287	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—DRD2—nicotine dependence	8.15e-05	0.000284	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—OPRM1—nicotine dependence	8.14e-05	0.000284	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKR1B10—nicotine dependence	8.11e-05	0.000283	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—DRD2—nicotine dependence	8.08e-05	0.000282	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—WASF2—nicotine dependence	8.04e-05	0.00028	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—WASF1—nicotine dependence	7.9e-05	0.000275	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—WASF2—nicotine dependence	7.87e-05	0.000274	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—DRD2—nicotine dependence	7.79e-05	0.000272	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—DRD2—nicotine dependence	7.79e-05	0.000272	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—WASF2—nicotine dependence	7.75e-05	0.00027	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—WASF2—nicotine dependence	7.71e-05	0.000269	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—WASF1—nicotine dependence	7.71e-05	0.000269	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—WASF1—nicotine dependence	7.55e-05	0.000263	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—DRD2—nicotine dependence	7.51e-05	0.000262	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—WASF1—nicotine dependence	7.43e-05	0.000259	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—WASF1—nicotine dependence	7.39e-05	0.000258	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—OPRM1—nicotine dependence	7.11e-05	0.000248	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—DRD2—nicotine dependence	7.08e-05	0.000247	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—OPRM1—nicotine dependence	6.94e-05	0.000242	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—OPRM1—nicotine dependence	6.8e-05	0.000237	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—WASF2—nicotine dependence	6.7e-05	0.000233	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—OPRM1—nicotine dependence	6.69e-05	0.000233	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—DRD2—nicotine dependence	6.68e-05	0.000233	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—OPRM1—nicotine dependence	6.66e-05	0.000232	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—DRD2—nicotine dependence	6.59e-05	0.00023	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—WASF2—nicotine dependence	6.45e-05	0.000225	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—WASF1—nicotine dependence	6.42e-05	0.000224	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—DRD2—nicotine dependence	6.25e-05	0.000218	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—WASF1—nicotine dependence	6.19e-05	0.000216	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—DRD2—nicotine dependence	5.89e-05	0.000205	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—OPRM1—nicotine dependence	5.78e-05	0.000202	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WASF2—nicotine dependence	5.71e-05	0.000199	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—OPRM1—nicotine dependence	5.57e-05	0.000194	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WASF1—nicotine dependence	5.48e-05	0.000191	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP2A7—nicotine dependence	5.33e-05	0.000186	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DRD2—nicotine dependence	5.14e-05	0.000179	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DRD2—nicotine dependence	5.02e-05	0.000175	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—OPRM1—nicotine dependence	4.93e-05	0.000172	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD2—nicotine dependence	4.91e-05	0.000171	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD2—nicotine dependence	4.84e-05	0.000169	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD2—nicotine dependence	4.81e-05	0.000168	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD2—nicotine dependence	4.18e-05	0.000146	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD2—nicotine dependence	4.03e-05	0.00014	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD2—nicotine dependence	3.57e-05	0.000124	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	3.29e-05	0.000115	CbGpPWpGaD
